-
2025-523553-34-00
1
2026-04-15
Advanced and Metastatic Solid tumors
-
2025-524542-10-00
4
2026-04-14
Endometrial cancer
-
2025-522403-17-00
5
2026-04-10
Nummular Dermatitis
-
2025-523263-37-00
10
2026-04-08
Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal
-
2024-517490-24-00
4
2026-03-31
Small Cell Lung Cancer
-
2025-521859-23-00
9
2026-03-31
PSMA-positive mCRPC with prior exposure to at least one prior ARPI
-
2025-523224-45-00
10
2026-03-30
Untreated, Unresectable or Metastatic Colorectal Cancer
-
2025-521286-27-00
10
2026-03-26
Immune-mediated thrombocytopenia, Autoimmune thrombocytopenia, Autoimm
-
2025-522046-42-00
5
2026-03-24
Colonic disease
-
2025-522674-36-00
5
2026-03-24
Metabolic Dysfunction-Associated Steatotic Liver Disease
-
2024-520026-11-00
7
2026-03-19
Metastatic Prostate Cancer
-
2024-519344-32-00
9
2026-03-16
Non-small Cell Lung Cancer
-
2025-521416-19-00
4
2026-03-12
Recurrence of Clostridioides difficile Infection
-
2025-521117-88-00
5
2026-03-11
Cardiovascular Disease
-
2025-521319-38-00
4
2026-03-11
metastatic colorectal cancer
-
2025-521284-12-00
5
2026-03-05
Non-small cell lung cancer
-
2024-517979-20-00
9
2026-03-04
Advanced Breast Cancer
Metastatic Breast Cancer
-
2025-520801-12-00
4
2026-03-03
Acute myocardial infarction in patients presenting with STEMI and mult
-
2025-522873-12-00
5
2026-02-24
ER+, HER2- Advanced Breast Cancer
-
2024-511362-37-00
5
2026-02-18
Non squamous non-small cell lung cancer (NSCLC)
-
2024-519366-52-00
4
2026-02-17
End-Stage Kidney Disease
-
2025-521904-23-00
4
2026-02-17
Locally Advanced Inoperable or Metastatic Breast Cancer Refractory to
-
2024-516966-12-00
4
2026-02-13
Alzheimer’s disease
-
2025-521124-29-00
10
2026-02-13
Non-Small Cell Lung Cancer